Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-24

Clinical Trial Update: Acrysof Toric SN60T3corneal Astigmatism Between 0.75 and 1.00 D. [NA]

View source ↗

Summary

The document reports the completion of a clinical trial evaluating the Acrysof Toric SN60T3 intraocular lens for correcting mild corneal astigmatism (0.75 to 1.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acrysof Toric SN60T3

Snippet

Sponsor: Medical University of South Carolina | Conditions: Cataracts | NA | Status: COMPLETED